European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf ). My lab is part of the new COST action on “Drug development in parasitic diseases” CM0801 (http://www.costcm0801.org/CM0801/Welcome.html ) 2008-2012. The initiative is reported in the following text: 2008 | Action Number: B22 In Vitro and In Vivo Screenings of New Antiparasitic Compounds: State-of-the-art and New Developments Pages: 92 Author(s): Reto Brun, Donatella Taramelli Publisher(s): Swiss Tropical Institute Joint meeting of COST B22 WG3 Drug Evaluation, WG4 Preclinical Research and EU-IP Antimal.

European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012 / Costi, Maria Paola; Ferrari, Stefania. - (2012).

I documenti presenti in Iris Unimore sono rilasciati con licenza Creative Commons Attribuzione - Non commerciale - Non opere derivate 3.0 Italia, salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Powered by IRIS-about IRIS-Utilizzo dei cookie

 Copyright © 2021